The AOA reaches out to media outlets across the country to inform consumers of the importance of eye health and vision care provided by optometrists. You can do the same in your local community by utilizing the customizable resources on this page.
Public education and campaign materials
Available for your use are customizable news releases, social media posts, infographics and other campaign resources that cover a number of vision and eye-health related topics. Not only are these tools useful to educate your patients and the public, but they provide an opportunity for you to market your practice and services to your community.
Also available are PowerPoint presentations that can be used for health events, school meetings and other assemblies.
Questions? Please email Susan Thomas.
Handouts, presentations & infographics
- Children’s Eye Health Activity Sheet
- Children's Screen Time Social Media Video
- Children’s Vision (Overview)
- Children’s Vision State Legislation / Advocacy Resources (Children's Vision Advocacy Toolkit)
- Key Components for Comprehensive Eye & Vision Examination in School-Age Children Vision Exam Fact Sheet
- AOA Pediatric Guidelines 6-Page Summary
- AOA Pediatric Guidelines For Health Care Providers
- Scout Vision Patch Awareness Program
- Sports and Performance Vision Toolkit
Digital Eye Strain
General Eye Health and Vision
Smoking and Eyes
- Fact Sheet
- Press Release
- Social Media Posts
- Content Messaging Resources
- Great American Smokeout Materials
We all see patients with mild vision loss who say their vision does not allow them to read the way they once could. Consider these strategies when refraction doesn’t yield a vision improvement and further disease treatment isn’t warranted.
Texas becomes the latest state to achieve a significant scope expansion in 2021, earning doctors’ authority to prescribe oral eye medications and independently manage glaucoma.
A new study reports partial recovery of visual function in a patient with late-stage retinitis pigmentosa using optogenetic therapy, a first for researchers looking into the neurodegenerative disease.